Apsis Aerocom

Apsis Aerocom

CLOSED

IPO Date: 11 Mar - 13 Mar 2026

Listing Date: 18 Mar 2026

Price Range

Rs.104 - Rs.110

Issue Size

36 Cr

Min Investment

1,24,800

Lot Size

1200 Shares

Schedule of Apsis Aerocom

Issue open date

11 Mar 2026

Issue close date

13 Mar 2026

UPI mandate deadline

13 Mar 2026 (5 PM)

Allotment finalization

16 Mar 2026

Share credit

17 Mar 2026

Listing date

18 Mar 2026

Mandate end date

28 Mar 2026

Issue size

Funds Raised in the IPOAmount
Overall36 Cr
Fresh Issue35.77 Cr
Offer for Sale0 Cr

Allotment DetailsNew

Allotment TimelineDetails
Allotment Date16 Mar 2026
Allotment Link{Link}

Grey Market PremiumNew

Grey Market Premium (GMP) is the premium at which the shares are traded in the grey market. It gives a fair idea about the listing price of the IPO shares. The GMP can be positive or negative based on the demand and supply of the shares in the grey market.

DateIpo PriceGMPEstimated Listing Price
17 Mar 202611026136 (23.64%)
15 Mar 202611018128 (16.36%)
14 Mar 202611017127 (15.45%)
12 Mar 202611018128 (16.36%)
10 Mar 20261109119 (8.18%)
9 Mar 20261100110 (0%)
8 Mar 20261100110 (0%)
7 Mar 20261100110 (0%)
6 Mar 20261100110 (0%)
5 Mar 20261100110 (0%)

Performance Apsis Aerocom

Issue PriceListing GainCurrent Market PriceP/L
Rs.104 - Rs.110 287 (39.09%) 186.4569.50%

About Apsis Aerocom

Apsis Aerocom Limited operates in the field of precision engineering, primarily engaged in the manufacture of components and provision of allied engineering services for the aerospace, defence and healthcare industries. The company focuses on precision machining and engineering solutions, offering services that range from design support and process planning to machining, surface finishing, quality inspection, and final product delivery. Its manufacturing processes emphasise dimensional accuracy and adherence to stringent quality standards. The company maintains quality management systems aligned with internationally recognised standards, including AS9100D and ISO 9001:2015, which are commonly adopted in the aerospace and precision engineering sectors. Its products generally consist of machined components manufactured based on customer-supplied designs and technical specifications, supporting complex systems used in aerospace, defence, and healthcare applications. The company operates a manufacturing facility at Peenya Industrial Area, Bengaluru, Karnataka, equipped with CNC machines capable of machining components up to 1,200 mm in length. The facility supports CAD/CAM-based design, process development, and precision machining activities. Within India, the company has established business relationships with customers primarily in Karnataka, Telangana, and Maharashtra. Internationally, it has served customers in markets such as the United States, the Netherlands, Spain, and Israel. The company also periodically evaluates opportunities to expand production capacity and strengthen supply chain capabilities in response to evolving demand from domestic and international aerospace and defence clients.

Founded in2012
Managing directorMr. Basavaraju Kanakatte Shivakumar
Parent organization

Financial Overview

Strengths

  • Strong focus on precision engineering for aerospace, defence, and healthcare sectors.
  • Provides end-to-end solutions from design support to final component delivery.
  • Certified quality systems aligned with AS9100D and ISO 9001:2015 standards.
  • Modern manufacturing facility in Bengaluru with advanced CAD/CAM machining capabilities.
  • Experienced promoters with strong industry knowledge and operational involvement.

Risks

  • Any disruption at the manufacturing facility could impact operations and revenue.
  • Dependence on a skilled workforce and key management for business continuity.
  • Exposure to regulatory and policy changes in the aerospace and defence industries.
  • Delay or failure in customer receivable collections could affect cash flows.
  • Business performance may be influenced by macroeconomic and market conditions.

Subscription Figures

CategorySubscription (No. of times)
Qualified Institutional Buyers (QIBs)99.96
Non-Institutional Investors (NIIs)174.32
Retail Individual Investors (RIIs)96.86
EmployeeN/A
Total118.58